Literature DB >> 21707866

Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.

Maura Di Vito1, Elena De Santis, Giulietta Anna Perrone, Emanuela Mari, Maria Chiara Giordano, Enrico De Antoni, Luigi Coppola, Guido Fadda, Marco Tafani, Angelo Carpi, Matteo A Russo.   

Abstract

The expression pattern of estrogen receptor (ER) isoforms in normal and tumor thyroid tissues is still controversial and poor defined, therefore, a more detailed study of the distribution of these molecules is needed. Most discrepancies might be due to the methods utilized. We studied the expression of ER isoforms in human papillary thyroid carcinoma (PTC), in fine-needle aspiration biopsy-derived specimens, and in cells, using more accurate techniques, such as laser-capture microdissection, real-time quantitative PCR, and Western blot. Laser-capture microdissection allowed us to isolate homogeneous cell populations from human PTC surgical samples. Tumor, peritumor, or normal host tissue of the same sample were separately dissected and analyzed by RT-PCR and Western blot. Estrogen receptor-α mRNA was more expressed in cancer-microdissected cells from human PTC, as compared with microdissected cells obtained from surrounding normal host tissue (450 vs 12, P = 0.001). A similar pattern was observed with Western blot for the ER-a protein. By contrast, ER-β mRNA expression was not detected among the microdissected tissue fractions. Fine-needle aspiration biopsy-derived specimens showed a similar expression pattern to ER. Moreover, human PTC cell line BCPAP and cancer stem cells from PTC, analyzed under hypoxic conditions, showed a hypoxia-driven increase in ER-α expression. In conclusion, ER-α might have an important role in human PTC, and its overexpression can be studied in routine needle aspirate as a possible marker of malignancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21707866     DOI: 10.1111/j.1349-7006.2011.02017.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  15 in total

1.  Hypoxia differentially regulates estrogen receptor alpha in 2D and 3D culture formats.

Authors:  Nathan A Whitman; Zhi-Wei Lin; Rachael M Kenney; Leonardo Albertini; Matthew R Lockett
Journal:  Arch Biochem Biophys       Date:  2019-06-01       Impact factor: 4.013

2.  Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.

Authors:  Fenghua Zhang; Li Xu; Qingyi Wei; Xicheng Song; Erich M Sturgis; Guojun Li
Journal:  Surgery       Date:  2012-12-04       Impact factor: 3.982

Review 3.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

Review 4.  Female Reproductive Factors and Differentiated Thyroid Cancer.

Authors:  Mariacarla Moleti; Giacomo Sturniolo; Maria Di Mauro; Marco Russo; Francesco Vermiglio
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-23       Impact factor: 5.555

Review 5.  The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis.

Authors:  Caroline C Faria; Milena S Peixoto; Denise P Carvalho; Rodrigo S Fortunato
Journal:  Oxid Med Cell Longev       Date:  2019-01-09       Impact factor: 6.543

Review 6.  Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.

Authors:  Ana Božović; Vesna Mandušić; Lidija Todorović; Milena Krajnović
Journal:  Int J Mol Sci       Date:  2021-02-06       Impact factor: 5.923

7.  Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.

Authors:  Yanhong Huang; Wenwu Dong; Jing Li; Hao Zhang; Zhongyan Shan; Weiping Teng
Journal:  BMC Cancer       Date:  2014-05-29       Impact factor: 4.430

8.  Expression of estrogen and progesterone receptors in papillary thyroid carcinoma.

Authors:  Mohammad-Reza Jalali-Nadoushan; Reza Amirtouri; Ali Davati; Samaneh Askari; Sepideh Siadati
Journal:  Caspian J Intern Med       Date:  2016

9.  Low dose of Bisphenol A enhance the susceptibility of thyroid carcinoma stimulated by DHPN and iodine excess in F344 rats.

Authors:  Jing Zhang; Xiaochen Zhang; Yanan Li; Zhenzhen Zhou; Chuanlong Wu; Zhiyan Liu; Lanxiang Hao; Shanshan Fan; Fang Jiang; Yan Xie; Ling Jiang
Journal:  Oncotarget       Date:  2017-07-22

10.  PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.

Authors:  Yi-Bo Qiu; Ling-Yao Liao; Rong Jiang; Man Xu; Lin-Wan Xu; George G Chen; Zhi-Min Liu
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.